Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life

PURPOSE: Treatment of severe asthma has made great strides thanks to rapid progress in understanding immune response and inflammatory pathways. This led to the advent of the first biologic for severe allergic asthma (SAA), omalizumab. Although the long-term efficacy and safety of omalizumab has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzella, Francesco, Fontana, Matteo, Contoli, Marco, Ruggiero, Patrizia, Galeone, Carla, Capobelli, Silvia, Simonazzi, Anna, Catellani, Chiara, Scelfo, Chiara, Castagnetti, Claudia, Livrieri, Francesco, Facciolongo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039243/
https://www.ncbi.nlm.nih.gov/pubmed/35495876
http://dx.doi.org/10.2147/JAA.S363398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039243/
https://www.ncbi.nlm.nih.gov/pubmed/35495876
http://dx.doi.org/10.2147/JAA.S363398

Ejemplares similares